| Application no. and date | 14836392.2 (espacenet) (Federated) (European Patent Register), 20140807 | | Patent/reg. no. and date | DK/EP 3033103, 20190605 | | Publication date | 20160622 | | Priority no. and date | US 201361864950 P, 20130812 | | EP pub. no. and date |
EP 3033103 20160622 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | 1506458 | | Inventor | WARD, Christine, C/o Medlmmune Llc
One Medlmmune Way
Gaithersburg, MD 20878, US,
ROSKOS, Lorin, C/o Medlmmune Llc
One Medlmmune Way
Gaithersburg, MD 20878, US,
WANG, Bing, C/o Medlmmune Llc
One Medlmmune Way
Gaithersburg, MD 20878, US,
RAIBLE, Donald, 317 Lenape Drive
Berwyn, PA 19312, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , G01N 33/48 (2006.01) | | Title | FREMGANGSMÅDE TIL FORBEDRING AF ASTMASYMPTOMER VED ANVENDELSE AF BENRALIZUMAB | | Int. application no. | US2014050122 | | Int. publication no. | WO2015023508 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
